A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation

7.4K views

DOI:

10.3791/55546

April 13th, 2017

In This Article

Summary

Next generation electroporation is an efficient method for transfecting human Th17 cells with small RNAs to alter gene expression and cell behavior.

Abstract

CD4+ T cells can differentiate into several subsets of effector T helper cells depending on the surrounding cytokine milieu. Th17 cells can be generated from naïve CD4+ T cells in vitro by activating them in the presence of the polarizing cytokines IL-1β, IL-6, IL-23, and TGFβ. Th17 cells orchestrate immunity against extracellular bacteria and fungi, but their aberrant activity has also been associated with several autoimmune and inflammatory diseases. Th17 cells are identified by the chemokine receptor CCR6 and defined by their master transcription factor, RORγt, and characteristic effector cytokine, IL-17A. Optimized culture conditions for Th17 cell differentiation facilitate mechanistic studies of human T cell biology in a controlled environment. They also provide a setting for studying the importance of specific genes and gene expression programs through RNA interference or the introduction of microRNA (miRNA) mimics or inhibitors. This protocol provides an easy to use, reproducible, and highly efficient method for transient transfection of differentiating primary human Th17 cells with small RNAs using a next generation electroporation device.

Introduction

CD4+ T cells are crucial orchestrators of the adaptive immune response. Naïve CD4+ T cells are capable of developing into several different effector T cells (e.g. Th1, Th2, Th17, etc.), each with their own set of characteristic cytokines and transcription factors, depending upon the local microenvironment1. The lineage decisions that T cells make are critical for both protective immunity and tolerance to self. Th17 cells are one subset of T cells known to combat extracellular bacteria and fungi, but their improper responses are also implicated in the pathogenesis of multiple autoimmune and inflammato....

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol adheres to UCSF's guidelines for human research ethics.

1. Preparation of T Cell Culture, Isolation of CD4+ T Cells, and Th17 Polarization

  1. On Day 0, coat 6-well tissue culture plates with 1.5 mL per well of anti-human CD3 (2 µg/mL) and anti-human CD28 (4 µg/mL) in PBS with calcium and magnesium for at least 2 h at 37 °C.
    1. Alternatively, coat the plates overnight at 4 °C. Wrap plates in parafilm.
  2. Prepare the cord blood mononuclear cells (CBMCs) by density gradient centrifugation per manufacturer's instructions.
    CAUTION....

Access restricted. Please log in or start a trial to view this content.

Results

The first step to developing a reliable system of successfully electroporating human Th17 cells was to generate robust in vitro differentiated human Th17 cell cultures. T cells cultured under Th17-polarizing conditions expressed the chemokine receptor CCR6 and the transcription factor RORγt (Figure 1A, left). These markers were not expressed when T cells were cultured under non-polarizing (ThN) conditions (Figure 1A, right). T cells cultured unde.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This protocol provides an improved method for the delivery of small RNAs into human Th17 cells. Although human Th17 cells were used here, this method of electroporation with small RNAs can be used with other primary human T helper subsets, such as Th1, Th2, and Tregs. It has not worked well for naïve CD4+ T cells so the cells must be activated in culture prior to transfection. For this protocol, we first optimized the in vitro culture system for better IL-17A production. The biggest factor was ba.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by the US National Institutes of Health grants (R01HL109102, P01HL107202, U19CA179512, F31HL131361), a Leukemia & Lymphoma Society scholar award (K.M.A.), and the National Institute of General Medical Sciences (NIGMS) Medical Scientist Training Program (Grant #T32GM007618) (M.M.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
anti-human IL-17A PEebioscience12-7179-42 Clone: eBio64DEC17
anti-human IFNg FITCebioscience11-7319-82Clone: 4S.B3
anti-human CD4 eVolve605ebioscience83-0047-42Clone: SK3
mouse anti-human CD196 (CCR6) BV421BD biosciences562515Clone: 11A9
anti-human RORgt AF647BD biosciences563620Clone: Q21-559
anti-human CD45 eFluor450ebioscience48-9459-42Clone: 2D1
Foxp3/Transcription Factor Staining Buffer Setebioscience00-5523-00For intracellular transcription factor flow cytometry staining
Hu FcR Binding Inhibitor Purifiedebioscience14-9161-71
ImmunoCult-XF T Cell Expansion MediumStemcell Technologies10981"Serum-Free Base Media"
MACS CD28 pure functional grade, humanMiltenyi Biotec130-093-375Clone: 15E8
anti-human CD3 PurifiedUCSF monoclonal antibody coreN/AClone: OKT-3
LEAF purified anti-human IL-4Biolegend500815Clone: MP4-25D2
anti-human IFNg, functional grade purifiedebioscience16-7318-85Clone: NIB42
Recombinant human IL-23Peprotech 200-23
Recombinant human IL-1βPeprotech 200-01B
Recombinant human TGF-β1Peprotech 100-21C
Recombinant human IL-6Peprotech 200-06
siGENOME Control Pool, Non-targeting #2DharmaconD-001206-14-05
siGENOME SMARTpool Human RORCDharmaconM-003442-00
siGENOME SMARTpool Human PTPRCDharmaconM-008067-01
Dynabeads Untouched Human CD4 T Cells KitThermoFisher Scientific11346DHuman CD4+ T cell Isolation Kit
Neon Tranfection SystemThermoFisher ScientificMPK5000Next generation electroporation instrument
Neon Tranfection System 10 μL KitThermoFisher ScientificMPK1096
Resuspension Buffer TThermoFisher ScientificProvided in kit (MPK1096)"Transfection Resuspension Buffer"
LymphoprepStemcell Technologies#07801Density Gradient Medium
costar 6-well tissue culture treated platesCorning3516flat bottom plates
costar 48-well tissue culture treated platesCorning3548flat bottom plates
BD Pharm Lyse lysing buffer, 10xBD biosciences555899Must make 1x solution with distilled water prior to use

References

  1. Zhu, J., Yamane, H., Paul, W. E. Differentiation of Effector CD4 T Cell Populations*. Ann Rev Immunol. 28 (1), 445-489 (2010).
  2. Korn, T., Bettelli, E., Oukka, M., Kuchroo, V. K. IL-17 and Th17 Cells. Ann Rev Immunol. 27 (1), 485-517 (2009).
  3. Gaffen, S. L., Jain, R., Garg, A. V., Cua, D. J.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Primary Human T CellsCD4 Positive T Cell IsolationTh17 Polarizing MediasiRNA TransfectionCCR6 Chemokine ReceptorROR Gamma T ExpressionIL 17A Production